CWA
ABBV icon

Cura Wealth Advisors’s AbbVie ABBV Stock Holding History

Cura Wealth Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$63.7M Buy
292,983
+11,157
+4% +$2.47M 28.52% 1
2025
Q4 		$64.4M Sell
281,826
-2,156
-0.8% -$491K 24.41% 1
2025
Q3 		$65.8M Sell
283,982
-28,493
-9% -$5.8M 25.13% 1
2025
Q2 		$58M Buy
312,475
+13,960
+5% +$2.59M 23.19% 1
2025
Q1 		$62.5M Sell
298,515
-1,137
-0.4% -$221K 25.31% 1
2024
Q4 		$53.2M Buy
+299,652
New +$55.1M 23.55% 1

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Cura Wealth Advisors's ABBV Position: Q1 2026 in Review

Cura Wealth Advisors increased its AbbVie (ABBV) stake by 4% in Q1 2026, buying an estimated $2.47M and bringing the position to 292,983 shares worth $63.7M. The position accounts for 28.52% of the portfolio, ranked #1.

Cura Wealth Advisors first reported a position in ABBV in Q4 2024 and has held it in 6 quarters since. The position peaked at $65.8M in Q3 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Cura Wealth Advisors held 292,983 shares of AbbVie worth $63.7M as of Q1 2026.
  • Cura Wealth Advisors bought 11,157 AbbVie shares in Q1 2026, an estimated $2.47M.
  • AbbVie made up 28.52% of Cura Wealth Advisors's portfolio in Q1 2026, its #1 holding.
  • Cura Wealth Advisors first reported a position in AbbVie in Q4 2024 and has held it in 6 quarters since.
  • Cura Wealth Advisors's AbbVie position peaked at $65.8M in Q3 2025.
  • 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Cura Wealth Advisors's 13F filing for Q1 2026, filed 8 May 2026.